VERTEX PHARMACEUTICALS INC / MA

VRTX

VERTEX PHARMACEUTICALS INC / MA

VRTX

Insider Sentiment (TTM):

Last Purchase:2025-08-06Last Sale:2026-06-26Shares Purchased (TTM):15,000Shares Sold (TTM):310,657

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:219,695,970Shares Outstanding:254,100,000Institutional Ownership Pct.:86.46%

Earnings Market Reaction:

Filing Date:2026-05-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	5,493	5,085	4,940	4,972	4,675	4,570	5,239	4,580	9,158	10,369	11,110	10,151
Marketable Securities Current	1,754	1,523	1,347	1,411	1,527	1,546	1,285	1,215	1,013	849	818	1,085
Accounts Receivable Net Current	1,996	2,053	1,946	1,894	1,805	1,609	1,751	1,656	1,793	1,563	1,539	1,556
Inventory Net	1,767	1,687	1,627	1,499	1,360	1,205	1,080	915	813	739	689	604
Prepaid Expense And Other Assets Current	721	853	709	652	643	666	449	575	511	624	540	477
Assets Current	11,730	11,201	10,570	10,428	10,009	9,596	9,804	8,942	13,289	14,144	14,696	13,873
Property Plant And Equipment And Finance Lease Rig…	1,608	1,520	1,425	1,335	1,296	1,228	1,118	1,201	1,173	1,159	1,124	1,122
Goodwill	1,088	1,088	1,088	1,088	1,088	1,088	1,088	1,088	1,088	1,088	1,088	1,088
Intangible Assets Net Excluding Goodwill	419	424	430	436	441	826	832	838	835	840	604	604
Deferred Income Tax Assets Net	2,948	2,898	2,937	2,712	2,544	2,331	2,309	2,186	1,963	1,812	1,729	1,538
Operating Lease Right Of Use Asset	1,685	1,563	1,592	1,314	1,339	1,357	1,396	570	313	294	311	324
Marketable Securities Noncurrent	5,750	5,712	5,723	5,646	5,157	5,108	4,704	4,393	4,381	2,498	1,700	1,357
Other Assets Noncurrent	1,256	1,237	1,098	1,079	1,007	999	990	916	876	895	475	443
Assets	26,484	25,643	24,862	24,037	22,881	22,533	22,240	20,132	23,917	22,730	21,726	20,349
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	489	462	420	442	445	413	396	328	351	365	376	363
Accrued Liabilities Current	2,984	2,971	3,614	3,271	2,952	2,789	3,220	2,940	2,796	2,655	2,907	2,598
Other Liabilities Current	407	428	442	425	386	363	358	279	649	527	316	391
Liabilities Current	3,881	3,861	4,475	4,138	3,783	3,565	3,973	3,547	3,796	3,547	3,599	3,352
Operating Lease Liability Noncurrent	1,987	1,847	1,835	1,527	1,538	1,544	1,589	587	360	349	354	364
Finance Lease Liability Noncurrent	-	-	-	-	111	113	114	347	362	376	390	404
Other Liabilities Noncurrent	1,255	1,270	1,233	1,196	952	1,015	933	877	854	878	869	759
Liabilities	7,123	6,977	7,544	6,861	6,384	6,124	6,609	5,357	5,371	5,150	5,213	4,879
Stockholders Equity Inclu…
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Commitments And Contingencies	-	-	-	-	-	0	0	0	0	0	0	0
Common Stock Value	3	3	3	3	3	3	3	3	3	3	3	3
Additional Paid In Capital Common Stock	4,743	5,119	5,012	5,988	6,173	6,672	6,906	7,101	7,285	7,450	7,340	7,369
Accumulated Other Comprehensive Income Loss Net Of…	25	-16	-65	-101	68	128	29	23	17	-14	-3	-40
Retained Earnings Accumulated Deficit	14,591	13,560	12,369	11,286	10,253	9,607	8,694	7,648	11,242	10,142	9,174	8,138
Stockholders Equity	19,362	18,666	17,319	17,175	16,496	16,410	15,631	14,775	18,547	17,580	16,513	15,470
Liabilities And Stockholders Equity	26,484	25,643	24,862	24,037	22,881	22,533	22,240	20,132	23,917	22,730	21,726	20,349
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	0	-	-	-	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	254	254	254	256	257	257	258	258	258	258	258	258
Shares Outstanding	254	254	254	256	257	257	258	258	258	258	258	258

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	5.46%	15.78%	12.49%	-	-	-	-	-	-	-	-	-
2025	-1.77%	-1.94%	4.36%	4.28%	2.87%	12.38%	2.83%	9.78%	11.08%	-7.08%	-10.74%	-13.74%
2024	10.99%	14.26%	20.72%	-2.67%	-5.97%	-2.32%	-6.35%	-18.23%	-12.05%	5.56%	2.60%	8.34%
2023	-	-	-	-2.33%	-2.47%	0.97%	-7.16%	7.57%	13.73%	-2.98%	-4.60%	-5.91%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.02	2.90	2.36	2.52	2.65	2.69	2.47	2.52	3.50	3.99	4.08	4.14
Quick Ratio	2.38	2.24	1.84	2.00	2.12	2.17	2.08	2.10	3.15	3.60	3.74	3.82
Working Capital	7.85B	7.34B	6.09B	6.29B	6.23B	6.03B	5.83B	5.39B	9.49B	10.60B	11.10B	10.52B
Leverage & Debt
Debt to Equity	0.37	0.37	0.44	0.40	0.39	0.37	0.42	0.36	0.29	0.29	0.32	0.32
Interest Coverage TTM	454.50	313.78	311.98	230.79	-32.00	-7.61	-5.43	-6.55	76.93	69.05	85.96	82.79
Debt Ratio	0.27	0.27	0.30	0.29	0.28	0.27	0.30	0.27	0.22	0.23	0.24	0.24
Efficiency & Turnover
Asset Turnover TTM	0.50	0.50	0.50	0.52	0.47	0.49	0.48	0.51	0.47	0.48	0.50	0.53
Days Sales Outstanding TTM	56.78	55.69	57.55	56.73	59.16	52.54	56.49	56.71	59.87	55.58	55.27	55.47
Receivables Turnover TTM	6.43	6.55	6.34	6.43	6.17	6.95	6.46	6.44	6.10	6.57	6.60	6.58
Per Share Metrics
Diluted EPS TTM	16.93	15.32	14.27	14.05	-3.81	-2.08	-1.84	-1.90	15.39	13.89	13.31	12.92
Free Cash Flow Per Share TTM	14.60	12.49	13.06	13.63	-4.87	-3.06	-4.29	-4.57	14.40	12.95	16.30	15.05
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	86.24%	86.24%	86.28%	86.11%	86.03%	86.11%	86.12%	86.45%	86.86%	87.21%	87.80%	87.92%
Operating Profit Margin TTM	38.31%	34.77%	34.06%	34.36%	-6.69%	-2.11%	-2.54%	-3.37%	41.16%	38.83%	40.16%	41.72%
Net Profit Margin TTM	35.51%	32.94%	31.35%	31.86%	-8.91%	-4.86%	-4.52%	-4.74%	39.46%	36.68%	35.94%	35.40%
Growth Metrics
Net Revenue Growth (1Y)	10.08%	8.90%	10.33%	10.46%	8.98%	11.66%	10.06%	8.76%	10.61%	10.51%	10.96%	13.83%
Net Income Growth (1Y)	-538.70%	-838.09%	-865.96%	-842.52%	-124.60%	-114.80%	-113.83%	-114.56%	23.31%	8.96%	6.00%	5.33%
EPS Growth (1Y)	-543.53%	-844.44%	-873.16%	-846.57%	-124.73%	-114.79%	-113.83%	-114.54%	22.92%	8.28%	5.39%	4.60%
Valuation Metrics
P/E TTM	26.15	29.32	27.24	31.42	-125.95	-193.91	-250.08	-246.94	26.85	28.97	25.86	26.95
P/B TTM	5.86	6.21	5.78	6.65	7.55	6.33	7.68	8.19	5.82	5.96	5.43	5.86
P/S TTM	9.29	9.66	8.54	10.01	11.22	9.42	11.29	11.70	10.60	10.62	9.29	9.54
Market Cap	113.47B	115.92B	100.10B	114.28B	124.55B	103.86B	119.99B	120.98B	107.93B	104.86B	89.72B	90.69B
Enterprise Value	107.96B	110.84B	95.16B	109.30B	119.98B	99.40B	114.86B	116.73B	99.12B	94.86B	78.99B	80.94B
Calculated Values
Free Cash Flow TTM	3.71B	3.19B	3.34B	3.50B	-1.25B	-790.30M	-1.11B	-1.18B	3.72B	3.34B	4.21B	3.88B
Net Debt	-5.50B	-5.09B	-4.95B	-4.98B	-4.57B	-4.46B	-5.13B	-4.24B	-8.81B	-10.00B	-10.73B	-9.75B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-26Sale

Owner: Bozic, Carmen

Title: EVP and CMO

Shares: 596

Price/Share: $482.50

Value: $287,570.00

Shares Owned: 15,337

Relationship: Officer

Ownership: Direct

2026-06-18Sale

Owner: Bozic, Carmen

Title: EVP and CMO

Shares: 1,020

Price/Share: $462.17

Value: $471,413.40

Shares Owned: 15,933

Relationship: Officer

Ownership: Direct

2026-06-15Sale

Owner: Bozic, Carmen

Title: EVP and CMO

Shares: 4,062

Price/Share: $450.00

Value: $1,827,900.00

Shares Owned: 16,953

Relationship: Officer

Ownership: Direct

2026-06-05Sale

Owner: Bozic, Carmen

Title: EVP and CMO

Shares: 1,745

Price/Share: $450.00

Value: $785,250.00

Shares Owned: 21,015

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Liu, Joy

Title: EVP and Chief Legal Officer

Shares: 828

Price/Share: $439.91

Value: $364,245.48

Shares Owned: 19,959

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-26	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	596	482.50	$287,570.00	15,337	4
2026-06-18	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	1,020	462.17	$471,413.40	15,933	4
2026-06-15	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	4,062	450.00	$1,827,900.00	16,953	4
2026-06-05	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	1,745	450.00	$785,250.00	21,015	4
2026-06-01	Liu, Joy	Officer	EVP and Chief Legal Officer	Direct	Sale	828	439.91	$364,245.48	19,959	4
2026-05-29	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	1,974	450.00	$888,300.00	22,760	4
2026-05-15	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	1,354	453.45	$613,971.30	24,734	4
2026-05-15	Bunnage, Mark E.	Officer	EVP, Chief Scientific Officer	Direct	Sale	33	453.45	$14,963.85	7,284	4
2026-05-12	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	6,988	450.00	$3,144,600.00	26,088	4
2026-05-04	Bhatia, Sangeeta N.	Director	-	Direct	Sale	318	423.73	$134,746.14	4,924	4
2026-05-01	Liu, Joy	Officer	EVP and Chief Legal Officer	Direct	Sale	1,104	425.02	$469,222.08	20,729	4
2026-04-01	Liu, Joy	Officer	EVP and Chief Legal Officer	Direct	Sale	978	449.17	$439,288.26	21,833	4
2026-03-27	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,329	450.95	$1,050,262.55	33,076	4
2026-03-13	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,329	481.79	$1,122,088.91	35,405	4
2026-03-11	Mckechnie, Duncan	Officer	EVP, Chief Commercial Officer	Direct	Sale	2,633	498.42	$1,312,339.86	12,489	4
2026-03-04	Mckechnie, Duncan	Officer	EVP, Chief Commercial Officer	Direct	Sale	2,437	475.30	$1,158,306.10	15,122	4
2026-03-02	Liu, Joy	Officer	EVP and Chief Legal Officer	Direct	Sale	892	495.96	$442,396.32	22,811	4
2026-02-27	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,329	480.31	$1,118,641.99	37,734	4
2026-02-27	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	40,000	489.75	$19,590,000.00	98,278	4
2026-02-26	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	357	483.36	$172,559.52	6,624	4
2026-02-25	Mckechnie, Duncan	Officer	EVP, Chief Commercial Officer	Direct	Sale	4,910	487.68	$2,394,508.80	17,559	4
2026-02-25	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	260	486.35	$126,451.00	46,763	4
2026-02-25	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	223	486.35	$108,456.05	6,981	4
2026-02-25	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	945	486.35	$459,600.75	13,659	4
2026-02-25	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	668	486.35	$324,881.80	18,432	4
2026-02-25	Bunnage, Mark E.	Officer	EVP, Chief Scientific Officer	Direct	Sale	620	486.35	$301,537.00	7,284	4
2026-02-25	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	1,846	486.35	$897,802.10	55,570	4
2026-02-19	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	58,613	467.83	$27,420,919.79	58,934	4
2026-02-18	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	1,244	473.68	$589,257.92	15,748	4
2026-02-18	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	638	473.68	$302,207.84	7,750	4
2026-02-18	Bunnage, Mark E.	Officer	EVP, Chief Scientific Officer	Direct	Sale	1,182	473.68	$559,889.76	8,486	4
2026-02-18	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	368	473.68	$174,314.24	48,650	4
2026-02-18	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	817	473.68	$386,996.56	20,727	4
2026-02-13	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	1,500	499.99	$749,985.00	46,132	4
2026-02-13	Bhatia, Sangeeta N.	Director	-	Direct	Sale	266	500.00	$133,000.00	4,299	4
2026-02-13	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	988	499.00	$493,012.00	16,838	4
2026-02-11	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	1,751	460.43	$806,212.93	22,046	4
2026-02-11	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	1,376	460.43	$633,551.68	10,127	4
2026-02-11	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	1,925	460.43	$886,327.75	20,819	4
2026-02-11	Bunnage, Mark E.	Officer	EVP, Chief Scientific Officer	Direct	Sale	2,021	460.43	$930,529.03	12,914	4
2026-02-11	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	466	460.43	$214,560.38	51,436	4
2026-01-07	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	4,500	474.99	$2,137,455.00	42,293	4
2026-01-06	Wagner, Charles F Jr	Officer	EVP, CO & FO	Direct	Sale	9,532	461.00	$4,394,252.00	37,725	4
2025-12-03	Wagner, Charles F Jr	Officer	EVP, CO & FO	Direct	Sale	14,000	456.00	$6,384,000.00	37,725	4
2025-12-03	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	63,781	447.70	$28,554,753.70	24,026	4
2025-12-03	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	347	449.00	$155,803.00	15,306	4
2025-12-03	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	4,500	449.99	$2,024,955.00	46,793	4
2025-11-17	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	2,500	434.58	$1,086,450.00	16,852	4
2025-11-14	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	53,604	441.22	$23,651,156.88	24,026	4
2025-10-02	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	694	404.21	$280,521.74	15,653	4
2025-08-27	Bhatia, Sangeeta N.	Director	-	Direct	Sale	266	386.69	$102,859.54	4,565	4
2025-08-06	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Purchase	10,000	389.52	$3,895,200.00	115,968	4
2025-08-06	Sachs, Bruce I	Director	-	Direct	Purchase	5,000	389.60	$1,948,000.00	45,000	4
2025-05-15	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	52	424.69	$22,083.88	23,281	4
2025-05-02	Bhatia, Sangeeta N.	Director	-	Direct	Sale	400	505.86	$202,344.00	4,831	4
2025-03-13	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	3,231	510.00	$1,647,810.00	23,281	4
2025-03-10	Wagner, Charles F Jr	Officer	EVP & Chief Financial Officer	Direct	Sale	3,298	500.00	$1,649,000.00	51,671	4
2025-03-10	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	3,231	500.00	$1,615,500.00	26,512	4
2025-03-10	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	3,242	499.99	$1,620,967.58	51,239	4
2025-03-04	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	4,058	485.49	$1,970,118.42	54,481	4
2025-03-03	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	3,231	490.00	$1,583,190.00	29,743	4
2025-02-27	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	2,650	475.34	$1,259,651.00	19,352	4
2025-02-27	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	530	475.34	$251,930.20	58,539	4
2025-02-27	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	1,272	480.00	$610,560.00	32,974	4
2025-02-25	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	354	480.95	$170,256.30	64,031	4
2025-02-25	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	884	480.95	$425,159.80	9,086	4
2025-02-25	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	1,767	480.95	$849,838.65	24,484	4
2025-02-25	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	848	480.95	$407,845.60	40,200	4
2025-02-20	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	1,111	480.00	$533,280.00	45,019	4
2025-02-18	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	671	455.06	$305,345.26	10,798	4
2025-02-18	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	1,657	455.06	$754,034.42	17,606	4
2025-02-18	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	244	455.06	$111,034.64	67,695	4
2025-02-11	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	310	459.83	$142,547.30	64,021	4
2025-02-11	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	1,747	459.83	$803,323.01	23,225	4
2025-02-11	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	1,376	459.83	$632,726.08	9,953	4
2025-02-11	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	3,433	459.87	$1,578,733.71	16,330	4
2024-11-15	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	15	478.56	$7,178.40	25,813	4
2024-11-11	Wagner, Charles F Jr	Officer	EVP & Chief Financial Officer	Direct	Sale	3,000	518.27	$1,554,810.00	44,137	4
2024-11-08	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	15,198	515.00	$7,826,970.00	75,772	4
2024-10-02	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	999	461.66	$461,198.34	16,651	4
2024-08-30	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	3,784	499.00	$1,888,216.00	9,994	4
2024-08-30	Bhatia, Sangeeta N.	Director	-	Direct	Sale	646	500.00	$323,000.00	4,435	4
2024-08-08	Bhatia, Sangeeta N.	Director	-	Direct	Sale	1,292	466.29	$602,446.68	4,435	4
2024-08-07	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,280	476.75	$1,086,990.00	23,259	4
2024-08-01	Sachs, Bruce I	Director	-	Direct	Sale	5,295	508.00	$2,689,860.00	40,000	4
2024-07-30	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	15,202	505.00	$7,677,010.00	90,970	4
2024-07-24	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,280	488.46	$1,113,688.80	25,539	4
2024-07-22	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	15,202	497.00	$7,555,394.00	106,172	4
2024-07-10	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,280	487.34	$1,111,135.20	27,819	4
2024-06-26	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,280	471.72	$1,075,521.60	30,099	4
2024-06-12	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,280	478.00	$1,089,840.00	32,379	4
2024-06-12	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	7,288	478.00	$3,483,664.00	15,972	4
2024-06-03	Wagner, Charles F Jr	Officer	EVP & Chief Financial Officer	Direct	Sale	3,250	460.00	$1,495,000.00	47,137	4
2024-06-03	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	2,175	460.00	$1,000,500.00	49,098	4
2024-05-31	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	2,250	445.00	$1,001,250.00	51,273	4
2024-05-29	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	2,280	445.56	$1,015,876.80	34,659	4
2024-05-28	Wagner, Charles F Jr	Officer	EVP & Chief Financial Officer	Direct	Sale	3,250	454.79	$1,478,067.50	50,387	4
2024-05-24	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	1,565	457.00	$715,205.00	121,374	4
2024-05-22	Sachs, Bruce I	Director	-	Direct	Sale	7,073	448.00	$3,168,704.00	40,000	4
2024-05-20	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	15,202	447.00	$6,795,294.00	121,374	4
2024-05-15	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	32	430.93	$13,789.76	55,325	4
2024-05-15	Altshuler, David	Officer	EVP, Chief Scientific Officer	Direct	Sale	54	430.93	$23,270.22	25,813	4
2024-05-15	Arbuckle, Stuart A	Officer	EVP, COO	Direct	Sale	69	430.93	$29,734.17	49,691	4
2024-05-02	Bhatia, Sangeeta N.	Director	-	Direct	Sale	467	402.95	$188,177.65	4,435	4
2024-04-02	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	240	419.00	$100,560.00	7,500	4
2024-02-26	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	883	425.70	$375,893.10	15,972	4
2024-02-26	Arbuckle, Stuart A	Officer	EVP, COO	Direct	Sale	5,034	425.70	$2,142,973.80	49,691	4
2024-02-26	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	354	425.70	$150,697.80	55,804	4
2024-02-26	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	883	425.70	$375,893.10	7,965	4
2024-02-26	Altshuler, David	Officer	EVP, Global Research and CSO	Direct	Sale	4,239	425.70	$1,804,542.30	25,813	4
2024-02-26	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	3,004	425.70	$1,278,802.80	55,325	4
2024-02-21	Altshuler, David	Officer	EVP, Global Research and CSO	Direct	Sale	3,002	421.77	$1,266,153.54	34,022	4
2024-02-21	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	360	421.77	$151,837.20	59,467	4
2024-02-21	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	1,201	421.77	$506,545.77	18,509	4
2024-02-21	Arbuckle, Stuart A	Officer	EVP, COO	Direct	Sale	3,603	421.77	$1,519,637.31	59,439	4
2024-02-21	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	3,191	421.77	$1,345,868.07	60,798	4
2024-02-20	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	4,254	420.79	$1,790,040.66	63,989	4
2024-02-20	Arbuckle, Stuart A	Officer	EVP, COO	Direct	Sale	4,804	420.79	$2,021,475.16	63,042	4
2024-02-20	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	801	420.79	$337,052.79	19,710	4
2024-02-20	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	480	420.79	$201,979.20	59,827	4
2024-02-20	Altshuler, David	Officer	EVP, Global Research and CSO	Direct	Sale	4,002	420.79	$1,684,001.58	37,024	4
2024-02-15	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	4,655	419.16	$1,951,189.80	17,896	4
2024-02-13	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	737	419.13	$308,898.81	26,907	4
2024-02-12	Atkinson, Edward Morrow I…	Officer	EVP, Chief Technical Ops. Off.	Direct	Sale	913	420.24	$383,679.12	23,137	4
2024-02-12	Altshuler, David	Officer	EVP, Global Research and CSO	Direct	Sale	3,145	420.24	$1,321,654.80	47,588	4
2024-02-12	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	1,738	418.77	$727,822.26	18,280	4
2024-02-12	Arbuckle, Stuart A	Officer	EVP, COO	Direct	Sale	4,295	420.24	$1,804,930.80	75,718	4
2024-02-12	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	3,222	420.24	$1,354,013.28	74,364	4
2024-02-12	Ambrose, Kristen	Officer	SVP & Chief Accounting Officer	Direct	Sale	1,374	420.24	$577,409.76	9,676	4
2024-02-12	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	314	420.24	$131,955.36	68,179	4
2024-01-08	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	6,648	419.07	$2,785,977.36	2,423	4
2024-01-02	Wagner, Charles F Jr	Officer	EVP & Chief Financial Officer	Direct	Sale	3,000	405.00	$1,215,000.00	43,693	4
2023-12-15	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	17,135	407.00	$6,973,945.00	108,711	4
2023-12-13	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	13,354	399.80	$5,338,929.20	9,071	4
2023-12-13	Arbuckle, Stuart A	Officer	EVP, COO	Direct	Sale	8,603	399.00	$3,432,597.00	56,556	4
2023-12-13	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	5,098	397.00	$2,023,906.00	108,711	4
2023-11-20	Wagner, Charles F Jr	Officer	EVP & Chief Financial Officer	Direct	Sale	3,000	349.88	$1,049,640.00	46,693	4
2023-11-15	Sachdev, Amit	Officer	EVP Chief Patient & Ext Af Off	Direct	Sale	35	369.92	$12,947.20	58,814	4
2023-11-15	Altshuler, David	Officer	EVP, Global Research and CSO	Direct	Sale	19	369.92	$7,028.48	32,038	4
2023-11-14	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	5,650	380.82	$2,151,633.00	29,302	4
2023-11-13	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	5,097	377.00	$1,921,569.00	113,809	4
2023-11-06	Sachs, Bruce I	Director	-	Direct	Sale	11,250	385.00	$4,331,250.00	40,000	4
2023-10-31	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	5,651	355.92	$2,011,303.92	34,952	4
2023-10-17	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	5,651	373.25	$2,109,235.75	40,603	4
2023-10-17	Bhatia, Sangeeta N.	Director	-	Direct	Sale	243	375.00	$91,125.00	3,901	4
2023-10-16	Leiden, Jeffrey M	Director,Officer	Executive Chairman	Direct	Sale	12,962	374.00	$4,847,788.00	22,425	4
2023-10-06	Bhatia, Sangeeta N.	Director	-	Direct	Sale	242	360.00	$87,120.00	4,144	4
2023-10-03	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	5,651	345.28	$1,951,177.28	46,254	4
2023-10-02	Biller, Jonathan	Officer	EVP and Chief Legal Officer	Direct	Sale	610	346.76	$211,523.60	10,569	4
2023-09-19	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	5,651	351.00	$1,983,501.00	51,905	4
2023-09-05	Bozic, Carmen	Officer	EVP and CMO	Direct	Sale	5,651	352.66	$1,992,881.66	57,556	4
2023-08-23	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	2,500	355.00	$887,500.00	48,637	4
2023-08-10	Kearney, Terrence C	Director	-	Direct	Sale	10,000	350.00	$3,500,000.00	6,536	4
2023-08-10	Tatsis, Ourania	Officer	EVP, Chief Reg. & Quality Off.	Direct	Sale	5,750	345.79	$1,988,292.50	51,137	4
2023-08-10	Sachdev, Amit	Officer	EVP, Chief Patient Officer	Direct	Sale	10,031	350.00	$3,510,850.00	58,814	4
2023-08-09	Altshuler, David	Officer	EVP, Global Research and CSO	Direct	Sale	63	345.51	$21,767.13	32,038	4
2023-08-09	Bhatia, Sangeeta N.	Director	-	Direct	Sale	242	345.51	$83,613.42	4,386	4
2023-07-17	Kewalramani, Reshma	Director,Officer	CEO & President	Direct	Sale	7,828	355.00	$2,778,940.00	118,906	4
2023-07-17	Sachs, Bruce I	Director	-	Direct	Sale	11,250	356.53	$4,010,962.50	40,000	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

86.46%

Inst. Shares: 219,695,970

Shares Outstanding: 254,100,000

2025-12-31

89.31%

Inst. Shares: 228,369,780

Shares Outstanding: 255,700,000

2025-09-30

87.77%

Inst. Shares: 224,338,451

Shares Outstanding: 255,600,000

2025-06-30

90.05%

Inst. Shares: 231,156,087

Shares Outstanding: 256,700,000

2025-03-31

86.78%

Inst. Shares: 222,942,439

Shares Outstanding: 256,900,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	219,695,970	254,100,000	86.46%
2025-12-31	228,369,780	255,700,000	89.31%
2025-09-30	224,338,451	255,600,000	87.77%
2025-06-30	231,156,087	256,700,000	90.05%
2025-03-31	222,942,439	256,900,000	86.78%
2024-12-31	223,707,885	257,900,000	86.74%
2024-09-30	219,719,563	258,000,000	85.16%
2024-06-30	222,198,374	258,100,000	86.09%
2024-03-31	213,344,193	258,200,000	82.63%
2023-12-31	215,381,161	257,700,000	83.58%
2023-09-30	211,266,497	258,000,000	81.89%
2023-06-30	213,181,179	257,700,000	82.72%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

VERTEX PHARMACEUTICALS INC / MA (VRTX) — SEC Financial Statements & Analysis

VERTEX PHARMACEUTICALS INC / MA (VRTX) is a pharmaceutical preparations company, incorporated in MA. VERTEX PHARMACEUTICALS INC / MA trades on VRTX: Nasdaq as: VRTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), VERTEX PHARMACEUTICALS INC / MA reported a 10.08% year-over-year revenue growth, a Gross Profit Margin of 86.24% (TTM), a Debt-to-Equity ratio of 0.37x, a Price-to-Sales (P/S) ratio of 9.29x (TTM), a Price-to-Book (P/B) ratio of 5.86 (TTM), at a market cap of $113.47B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 10.08%
Gross Profit Margin TTM: 86.24%
Debt To Equity: 0.37x
P/S TTM: 9.29x
P/B TTM: 5.86
Market Cap: $113.47B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is VERTEX PHARMACEUTICALS INC / MA in?

VERTEX PHARMACEUTICALS INC / MA (VRTX) operates in the Pharmaceutical Preparations industry.

What is VRTX's market cap?

VERTEX PHARMACEUTICALS INC / MA (VRTX) has a market capitalization of $113.47B as of 2026-03-31.

What is VRTX's P/E ratio?

VERTEX PHARMACEUTICALS INC / MA (VRTX)'s trailing twelve month P/E ratio is 26.15x as of 2026-03-31.

What exchange does VRTX trade on?

VERTEX PHARMACEUTICALS INC / MA (VRTX) trades on the VRTX: Nasdaq.

Where is VERTEX PHARMACEUTICALS INC / MA incorporated?

VERTEX PHARMACEUTICALS INC / MA is incorporated in MA.